Ke Wang
ORCID: 0000-0002-7447-2356Also affiliated with China University of Petroleum, Beijing, Cornell University, New York State College of Agriculture & Life Sciences, Institute of Plant Protection, Jilian Technology Group (China), PowerChina (China), Institute of High Energy Physics, Henan Agricultural University, Huazhong University of Science and Technology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 4 papers. Top paper: “Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial”.
Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin +41 more
Xiongqi Pang, Zhenkui Jin, Tao Hu, Abdulkareem Toyin, Ke Wang +1 more
Felicia Trachtenberg, Ke Wang, Karen Uzark, Erica Sood, Linda M. Lambert +10 more
Ke Wang, Jiaoyang Jiang, Chia‐Wei Hu